Literature DB >> 18539433

Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.

Brian D Hondowicz1, Michele L Fields, Simone A Nish, Joseph Larkin, Andrew J Caton, Jan Erikson.   

Abstract

In Fas/FasL-deficient mice anti-chromatin Ab production is T cell dependent and is not apparent until after 10 weeks of age. Early control of anti-chromatin antibodies may be due to the counterbalancing influence of Treg cells. Here we show that Treg cells block lpr/lpr gld/gld Th cells from providing help to anti-chromatin B cells in an in vivo transfer system. Interestingly, the percentage and absolute numbers of Foxp3+ Treg cells is elevated in BALB/c-lpr/lpr gld/gld mice and increases with age compared to BALB/c mice. The majority of Foxp3 expression is found in the B220- CD4+ T cell population, and Foxp3-expressing cells are localized in the splenic PALS (periarteriolar lymphocyte sheath). Strikingly, although the lack of functional Fas/FasL does not affect the ability of Treg cells to block Th cell proliferation, Treg cells can block the IFN-gamma differentiation of Th cells from BALB/c or young BALB-lpr/lpr gld/gld mice but not of pre-existing Th1 cells from older BALB/c-lpr/lpr gld/gld mice. Thus, we suggest autoantibody production is not caused by the lack of Treg cells but by a defect in activation-induced cell death that leads to the accumulation of T effector cells that are resistant to regulatory T cell activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539433      PMCID: PMC2585757          DOI: 10.1016/j.jaut.2008.04.022

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  53 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  T follicular helper (TFH) cells in normal and dysregulated immune responses.

Authors:  Cecile King; Stuart G Tangye; Charles R Mackay
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

3.  B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.

Authors:  J H Roark; C L Kuntz; K A Nguyen; L Mandik; M Cattermole; J Erikson
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

4.  Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells.

Authors:  W F Davidson; C Calkins; A Hügins; T Giese; K L Holmes
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

5.  Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.

Authors:  T Giese; W F Davidson
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

6.  Ontogeny and function of B220+ L3T4+ T-cell subset of MRL/Mp-lpr/lpr mice.

Authors:  A Kariyone; M Takiguchi; S Igarashi; K Kano
Journal:  Cell Immunol       Date:  1988-08       Impact factor: 4.868

7.  The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.

Authors:  T Shirai; M Abe; H Yagita; K Okumura; H C Morse; W F Davidson
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

8.  Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.

Authors:  D Watanabe; T Suda; H Hashimoto; S Nagata
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

9.  Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.

Authors:  J L Chu; P Ramos; A Rosendorff; J Nikolić-Zugić; E Lacy; A Matsuzawa; K B Elkon
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  5 in total

1.  Efficient help for autoreactive B-cell activation requires CD4+ T-cell recognition of an agonist peptide at the effector stage.

Authors:  Brian D Hondowicz; Amrita O Batheja; Michele H Metzgar; Antonio J Pagán; Olivia A Perng; Simone Willms; Andrew J Caton; Jan Erikson
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

2.  Glomerular cytokine expression in murine lupus nephritis.

Authors:  Kadiombo Anastasie Tshilela; Hidekazu Ikeuchi; Takayuki Matsumoto; Takashi Kuroiwa; Noriyuki Sakurai; Toru Sakairi; Yoriaki Kaneko; Akito Maeshima; Keiju Hiromura; Yoshihisa Nojima
Journal:  Clin Exp Nephrol       Date:  2015-05-19       Impact factor: 2.801

3.  Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

Authors:  Francesca Bernuzzi; Daniela Fenoglio; Florinda Battaglia; Marco Fravega; M Eric Gershwin; Francesco Indiveri; Aftab A Ansari; Mauro Podda; Pietro Invernizzi; Gilberto Filaci
Journal:  J Autoimmun       Date:  2010-07-16       Impact factor: 7.094

4.  Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells.

Authors:  Tuure Kinnunen; Nicolas Chamberlain; Henner Morbach; Jinyoung Choi; Sangtaek Kim; Joseph Craft; Lloyd Mayer; Caterina Cancrini; Laura Passerini; Rosa Bacchetta; Hans D Ochs; Troy R Torgerson; Eric Meffre
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

5.  Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Natalie Ridge; Michele Fields; Audrey Y Park; Jan Erikson
Journal:  Curr Opin Immunol       Date:  2008-09-18       Impact factor: 7.486

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.